Inhibition by amiloride of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
The effects of amiloride on the incidence and histological types of gastric cancers in Wistar rats induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), and on the labelling index and proliferative fraction of gastric mucosa were investigated. After oral treatment with MNNG for 25 weeks, rats received s.c. injections of amiloride (0.25 mg kg-1 or 5.0 mg kg-1 body weight) in depot form every other day until the end of the experiment. Prolonged administration of 5.0 mg kg-1, but not 2.5 mg kg-1 of amiloride significantly decreased the incidence of gastric cancers in Week 52. However, it did not influence the histological features of the gastric cancers. It also significantly decreased the labelling index and proliferative fraction of the antral mucosa. These findings indicate that amiloride inhibits the development of gastric cancers, and that its effect may be related to its effect in decreasing cell proliferation of the antral mucosa.
Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.
M
M
Tatsuta
H
H
Iishi
M
M
Baba
H
H
Uehara
A
A
Nakaizumi
H
H
Taniguchi
D000230:Adenocarcinoma / Q000139:chemically induced*; D000584:Amiloride / Q000494:pharmacology*; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D005753:Gastric Mucosa / Q000166:cytology / Q000187:drug effects; D008297:Male; D008769:Methylnitronitrosoguanidine; D051381:Rats; D017208:Rats, Wistar; D013274:Stomach Neoplasms / Q000139:chemically induced*
D008769:Methylnitronitrosoguanidine; D000584:Amiloride